A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : NAFLD

Search Conditions:
Search Keyword : NAFLD
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: NAFLD
Appearance Frequency: 17403 time(s)
Long forms: 20

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
nonalcoholic fatty liver disease
(17373 times)
Gastroenterology
(4048 times)
NASH (3180 times)
HFD (1075 times)
BMI (957 times)
1998 Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.
nonalcoholic FLD
(7 times)
Gastroenterology
(4 times)
FLD (7 times)
AFLD (4 times)
ALD (1 time)
2006 Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.
non-AFLD
(3 times)
Medical Informatics
(1 time)
AFLD (2 times)
AUC (1 time)
IMR-MS (1 time)
2009 A new ensemble-based algorithm for identifying breath gas marker candidates in liver disease using ion molecule reaction mass spectrometry.
NAFL disease
(2 times)
Gastroenterology
(1 time)
NAFL (2 times)
NASH (2 times)
HCF-1 (1 time)
2009 Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis.
NAFLD parents
(2 times)
Pediatrics
(2 times)
--- 2014 Parental perceptions regarding lifestyle interventions for obese children and adolescents with nonalcoholic fatty liver disease.
nonalcoholic fatty LD
(2 times)
Pediatrics
(1 time)
LD (2 times)
LT (1 time)
MIS-C (1 time)
2012 Common Digestive and Liver Diseases among 5880 Patients Admitted to Shariati Hospital,Tehran,Iran during 2000-2009.
manifestation-nonalcoholic liver disease
(1 time)
Gastroenterology
(1 time)
--- 2015 The Gut Microbiota and Nonalcoholic Fatty Liver Disease.
NAFLD compared with controls
(1 time)
Inflammation
(1 time)
sCD14 (1 time)
sTNF-RII (1 time)
T2DM (1 time)
2010 Elevated endotoxin levels in non-alcoholic fatty liver disease.
NAFLD defined by ultrasound
(1 time)
Medicine
(1 time)
HP (1 time)
OR (1 time)
2022 Non-alcoholic fatty liver disease is not independently associated with Helicobacter pylori in a Central European screening cohort.
10  NAFLD fibrosis score, FibroMeter
(1 time)
Gastroenterology
(1 time)
APRI (1 time)
LSM (1 time)
2016 Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.
11  NAFLD group
(1 time)
Pharmacology
(1 time)
BMI (1 time)
HbA1c (1 time)
HOMA (1 time)
2018 Analysis of the correlation between non-alcoholic fatty liver disease and bone metabolism indicators in healthy middle-aged men.
12  NAFLD mice treated with saline
(1 time)
Food
(1 time)
CON (1 time)
HFD (1 time)
PA (1 time)
2019 Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.
13  NAFLD model among various liver diseases compare to control
(1 time)
Neoplasms
(1 time)
G-CSF (1 time)
2017 Granulocyte colony stimulating factor treatment in non-alcoholic fatty liver disease: beyond marrow cell mobilization.
14  NAFLD without HCC
(1 time)
Internal Medicine
(1 time)
BMI (1 time)
CRP (1 time)
HbA1c (1 time)
2017 The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma.
15  NAFLD-only
(1 time)
Gastroenterology
(1 time)
FLD (1 time)
MAFLD (1 time)
2021 Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: Focusing on the non-overlap groups.
16  NFS.KEY MESSAGESNon-alcoholic fatty liver disease
(1 time)
Medicine
(1 time)
CI (1 time)
CP (1 time)
NFS (1 time)
2021 High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.
17  Non alcoholic fatty liver disease and fibrosis
(1 time)
Medicine
(1 time)
APRI (1 time)
NFI (1 time)
2022 Comparison of Novel Fibrosis Index (NFI) with Aspartate aminotransferase to platelet ratio index (APRI) in Type II Diabetes mellitus patients with Non alcoholic fatty liver disease and fibrosis (NAFLD).
18  non-fatty liver disease
(1 time)
Chemistry
(1 time)
SPPARgammaM (1 time)
T2D (1 time)
2021 Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview.
19  nonalcoholic fatty liver disease remains unknown
(1 time)
Complementary Therapies
(1 time)
MCD (1 time)
NASH (1 time)
2021 Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis.
20  number of HCCs developing on steatosis
(1 time)
Molecular Biology
(1 time)
HCC (1 time)
2017 Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment.